December 07, 2025 11:01 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Centre imposes temporary fare caps as ticket prices defy gravity amid IndiGo meltdown | 'Action is coming': Aviation Minister blames IndiGo for countrywide air travel chaos | In front of Putin, PM Modi makes bold statement on Russia-Ukraine war: ‘India is not neutral, we side with peace!’ | Rupee weakens following RBI repo rate cut | RBI slashes repo rate by 25 basis points — big relief coming for borrowers! | 'Mamata fooled Muslims': Humayun Kabir explodes after TMC suspends him over 'Babri Masjid-style mosque' demand; announces new party | Mosque in the middle of Kolkata airport? Centre confirms flight risks, BJP fires at Mamata | Sam Altman is betting big on India! OpenAI in advanced talks with Tata to build AI infrastructure | Government removes mandatory pre-installation of Sanchar Saathi App. Know all details | Calcutta HC overturns controversial Bengal job annulment — 32,000 teachers rejoice!

Russia now has three drugs that can help treat COVID-19: Russian Academy of Sciences

| @indiablooms | Mar 30, 2020, at 12:32 pm

Moscow/Sputnik/UNI: Three antiviral drugs that can be used to treat COVID-19 were developed in Russia in conjunction with scholars from the Russian Academy of Sciences; the academy's vice president and head of the biomedical sciences unit Vladimir Chekhonin told Sputnik.

Chekhonin stated that the antiviral drug triazavirin was created several years ago at the Institute of Organic Synthesis at the Urals branch of the Russian Academy of Sciences. This drug is now being tested by Chinese scientists for its ability to treat COVID-19.

“As of today, a special inhalant is ready, which can be used exclusively to treat viral respiratory infections. I am sure that it will be more than appropriate to treat COVID-19. And of course, having this option is extremely important in the current circumstances,” he said.

The leading academician also stated that another drug, based on the Japanese-made antiviral treatment favipiravir, has been created by the Institute of Organic Synthesis in conjunction with the Zelinsky Institute of Organic Chemistry in Moscow. This drug has been adapted to meet Russian standards, he said.

“As far as I know, this drug is ready to be tested in specialized clinics in Russia,” Chekhonin stated.

Another viral drug, fortepren, has also passed clinical trials and should be assessed for its ability to treat COVID-19, the academician stated.

“As for fortepren, it has passed all its clinical trials, that is, it was even tested in humans. It is currently awaiting registration, after which it can be submitted for trials to see if it can treat COVID-19,” Chekhonin remarked.

According to the academician, testing the ability of these three drugs to treat the coronavirus disease is a top priority of both the Russian Academy of Sciences and the Russian Ministry of Education and Science. 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.